Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. tomography
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Date

  • Older

Tomography Articles & Analysis: Older

83 news found

New Potential In Lung Fibrosis Treatment With Lung Cell Transplantation

New Potential In Lung Fibrosis Treatment With Lung Cell Transplantation

Idiopathic pulmonary fibrosis (IPF) remains a devastating condition with limited treatment options, often leading to a grim prognosis. However, a recent study by Milman-Krentsis (2024) offers a beacon of hope, demonstrating the potential of lung cell transplantation as a therapeutic intervention for lung fibrosis. Utilizing two distinct mouse models—one treated with bleomycin and another ...

BySCIREQ - an emka TECHNOLOGIES Company


Anuncia Medical Announces First Successful US Implant of the Company’s ReFlow Device with Sonolucent Cranial Plate to Noninvasively Visualize Flushing of Hydrocephalus Shunts

Anuncia Medical Announces First Successful US Implant of the Company’s ReFlow Device with Sonolucent Cranial Plate to Noninvasively Visualize Flushing of Hydrocephalus Shunts

Traditionally, the only way to image inside the cranial compartment was through Computerized Tomography (CT) or Magnetic Resonance Imaging (MRI), which can be time-consuming and may require sedation. ...

ByAnuncia Medical, Inc.


Bayer driving innovation in radiology with new research across the portfolio presented at ECR

Bayer driving innovation in radiology with new research across the portfolio presented at ECR

Potential ways to reduce the contrast media dose with the sharper injection bolus profile from the MEDRADTM Centargo CT Injection System, the latest addition to Bayer’s computed tomography portfolio designed to simplify radiology workflows, are the focus of another presentation at ECR. ...

ByBayer AG


Bayer completes acquisition of Blackford Analysis Ltd.

Bayer completes acquisition of Blackford Analysis Ltd.

Bayer offers a leading portfolio of contrast media for computed tomography (CT), X-Ray, and magnetic resonance imaging (MRI), devices for their precise administration, informatics solutions and a medical imaging platform delivering access to applications, including those enabled by AI. ...

ByBayer AG


Ultravist by Bayer now approved for contrast-enhanced mammography in EU

Ultravist by Bayer now approved for contrast-enhanced mammography in EU

About Ultravist Ultravist™ is an iodine-based contrast medium for X-ray techniques requiring contrast enhancement such as conventional radiography, angiography and computed tomography. Available in more than 100 countries, Ultravist is currently being applied more than 18 million times a year. ...

ByBayer AG


Bayer acquires Blackford Analysis Ltd. bolstering the company’s position in digital medical imaging

Bayer acquires Blackford Analysis Ltd. bolstering the company’s position in digital medical imaging

Bayer is offering a comprehensive portfolio of contrast media for computed tomography (CT), X-Ray, and magnetic resonance imaging (MRI), devices for their precise administration, informatics solutions as well as a medical imaging platform delivering access to applications, including those enabled by AI. ...

ByBayer AG


Perimeter Medical Imaging AI Announces Publication of Peer-Reviewed Journal Article Validating Potential Use of Wide-Field Optical Coherence Tomography (WF-OCT) in Head and Neck Surgeries

Perimeter Medical Imaging AI Announces Publication of Peer-Reviewed Journal Article Validating Potential Use of Wide-Field Optical Coherence Tomography (WF-OCT) in Head and Neck Surgeries

The study’s findings validate the further exploration of the use of Perimeter’s wide-field Optical Coherence Tomography (WF-OCT) technology to visualize margins during head and neck surgeries. ...

ByPerimeter Medical Imaging AI


CTT to Present Data on Prostate Cancer Therapy Candidates at Upcoming Conferences

CTT to Present Data on Prostate Cancer Therapy Candidates at Upcoming Conferences

CTT1057 is a diagnostic molecule used in positron emission tomography (PET) imaging, a type of molecular (also known as nuclear) imaging that uses small amounts of radioactive materials called radiotracers to evaluate organs and tissue functions. ...

ByCancer Targeted Technology


Prof. Krestin Joins Fluidda’S Board of Directors

Prof. Krestin Joins Fluidda’S Board of Directors

Patients already get diagnostic computerized tomography (CT) scans when recommended. Instead of adding an additional test, FRI would simply change the evaluation of these scans, providing more information along with a better way to visualize that information. ...

ByFluidda


FDA Approves Taiho’s LYTGOBI® (futibatinib) Tablets for Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma

FDA Approves Taiho’s LYTGOBI® (futibatinib) Tablets for Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma

Perform a comprehensive ophthalmological examination, including optical coherence tomography (OCT) of the macula, prior to initiation of therapy, every 2 months for the first 6 months, and every 3 months thereafter. ...

ByTaiho Oncology, Inc.


Adiposs starts clinical development of its flagship product ImageBAT

Adiposs starts clinical development of its flagship product ImageBAT

The secondary objective is to assess the imaging parameters of ImageBAT and demonstrate its performance in imaging brown fat by computed tomography (CT) scan. The phase 1 escalation study is taking place near Budapest, Hungary. ...

ByAdiposs


PharmAbcine Signs MoU with FutureChem to Explore Possibilities of Developing Novel Radiopharmaceuticals

PharmAbcine Signs MoU with FutureChem to Explore Possibilities of Developing Novel Radiopharmaceuticals

It also provides peptide-based radiopharmaceuticals for radio-metal chelation and click reaction; linkers for bio-conjugation using copper-free/mediated click reaction; fluorinated compounds; and custom synthesis services including Good Manufacturing Practice (GMP)-produced drugs for clinical trials, as well as develops and produces PET and single photon emission computed ...

ByPharmAbcine Inc.


Perimeter Medical Imaging AI and Pavilion Surgery Center Announce Placement of Perimeter S-Series OCT for Use at Ambulatory Surgery Center in Orange, CA

Perimeter Medical Imaging AI and Pavilion Surgery Center Announce Placement of Perimeter S-Series OCT for Use at Ambulatory Surgery Center in Orange, CA

Perimeter S-Series OCT received FDA 510(k) clearance in 2021 and is a medical imaging tool that uses Optical Coherence Tomography (OCT) to provide clinicians with cross-sectional, real-time margin visualization (1-2 mm below the surface) of an excised tissue specimen. ...

ByPerimeter Medical Imaging AI


The Lancet Oncology: 66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics’ VivoSight OCT laser scanner

The Lancet Oncology: 66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics’ VivoSight OCT laser scanner

A major study published in leading cancer journal, The Lancet Oncology1 have ground-breaking findings on Michelson Diagnostics, the UK based medical device company that use multi-beam Optical Coherence Tomography (‘OCT’) technology, which can transform patient’s treatment and care of basal cell carcinomas (BCC). ...

ByMichelson Diagnostics Ltd. (MDL)


Todd C. Villines, M.D. Joins Elucid as new Chief Medical Officer

Todd C. Villines, M.D. Joins Elucid as new Chief Medical Officer

Villines is board-certified in internal medicine, cardiovascular diseases, cardiac computed tomography, and advanced adult echocardiography. He is a former president of the Society of Cardiovascular ComputedTomography and Editor in Chief of the Journal of Cardiovascular Computed Tomography. ...

ByElucid


Diffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor Oxygenation

Diffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor Oxygenation

Diffusion aligns with FDA on design of an open-label, dose-escalation, Phase 2 safety and efficacy study of trans sodium crocetinate (“TSC”) in newly diagnosed glioblastoma multiforme (“GBM”) patients Company to evaluate effects of TSC on tumor oxygenation using an innovative positron emission tomography (“PET”) hypoxia imaging methodology ...

ByCervoMed


electroCore, Inc. Announces Study of gammaCore Sapphire for the Treatment of Post-COVID Syndrome

electroCore, Inc. Announces Study of gammaCore Sapphire for the Treatment of Post-COVID Syndrome

Endpoints of the study include a number of clinical questionnaires including the Post-COVID Functional Status Score, as well as an analysis of blood samples for certain chemokines, and positron emission tomography-computed tomography (PET-CT) of the brain to evaluate brain metabolism. ...

ByelectroCore, Inc.


Bayer expands Radiology Business into AI Market with Calantic Digital Solutions

Bayer expands Radiology Business into AI Market with Calantic Digital Solutions

Bayer has a leading portfolio of contrast media for computed tomography (CT), X-Ray, and magnetic resonance imaging (MRI), devices for their precise administration, informatics solutions to support efficient and optimized patient care, as well as acknowledged educational programs that generated €1.8bn sales in 2021. ...

ByBayer AG


XyloCor Therapeutics Announces Presentation of Preliminary Clinical Data from Phase 1 Portion of the EXACT Phase 1/2 Study of XC001 Novel Gene Therapy for Refractory Angina at AATS and ASGCT

XyloCor Therapeutics Announces Presentation of Preliminary Clinical Data from Phase 1 Portion of the EXACT Phase 1/2 Study of XC001 Novel Gene Therapy for Refractory Angina at AATS and ASGCT

Safety, efficacy and tolerability evaluations were measured as adverse events (AEs), serious adverse events (SAEs) and change from baseline from three to six months post-treatment in exercise capacity, ischemic burden by positron emission tomography (PET) imaging, and patient-reported symptomatology. No drug-related SAEs, bleeding complications or ventricular arrhythmias were ...

ByXyloCor Therapeutics


Thoma Bravo Completes Strategic Growth Investment in Circle Cardiovascular Imaging

Thoma Bravo Completes Strategic Growth Investment in Circle Cardiovascular Imaging

Circle CVI is the leading provider of AI-based cardiac imaging and reporting solutions, including cardiac MRI ("CMR") and cardiac computerized tomography ("CT") imaging post-processing software. The company has developed a deep portfolio of specialized, accurate and intuitive solutions that are an integral part of precision medicine and enable physicians to deliver the highest ...

ByCircle Cardiovascular Imaging Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT